[ad_1]
The move was enough to erase the stock’s year-to-date gains and mark the worst two-day stretch for the stock in more than two years.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...